Testing effectiveness (Phase 2)UnknownNCT01760811
What this trial is testing
CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT
Who this might be right for
Squamous Cell Carcinoma
Rabin Medical Center 25